{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:25:51Z","timestamp":1788452751762,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00105-026-05760-9","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:22:04Z","timestamp":1787649724000},"page":"584-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Klinik und Diagnostik von bradykininvermittelten Angio\u00f6demen","Clinical presentation and diagnosis of bradykinin-mediated angioedema"],"prefix":"10.1007","volume":"77","author":[{"given":"Susanne","family":"Trainotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Undine","family":"Lippert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"5760_CR1","doi-asserted-by":"crossref","unstructured":"Guan X, Sheng Y, Liu S et\u00a0al. (2024) Epidemiology, economic, and humanistic burden of hereditary angioedema: a\u00a0systematic review. Orphanet J Rare Dis 19:256","DOI":"10.1186\/s13023-024-03265-z"},{"key":"5760_CR2","doi-asserted-by":"crossref","unstructured":"Bork K, Hardt J, Witzke G (2012) Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J\u00a0Allergy Clin Immunol 130:692\u2013697","DOI":"10.1016\/j.jaci.2012.05.055"},{"key":"5760_CR3","unstructured":"Farkas H, Martinez-Saguer I, Bork K et\u00a0al. (2026) International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema. Allergy"},{"key":"5760_CR4","doi-asserted-by":"crossref","unstructured":"Aygoren-Pursun E, Bygum A, Beusterien K et\u00a0al. (2014) Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet J Rare Dis 9:99","DOI":"10.1186\/1750-1172-9-99"},{"key":"5760_CR5","doi-asserted-by":"crossref","unstructured":"Bork K, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Bas M et\u00a0al. (2019) Guideline: Hereditary angioedema due to C1 inhibitor deficiency. Allergo Journal International\u00a028:16\u201329","DOI":"10.1007\/s40629-018-0088-5"},{"key":"5760_CR6","doi-asserted-by":"crossref","unstructured":"Ohsawa I, Fukunaga A, Imamura S et\u00a0al. (2021) Survey of actual conditions of erythema marginatum as a\u00a0prodromal symptom in Japanese patients with hereditary angioedema. World Allergy Organ J 14:100511","DOI":"10.1016\/j.waojou.2021.100511"},{"key":"5760_CR7","doi-asserted-by":"crossref","unstructured":"Martinez-Saguer I, Farkas H (2016) Erythema Marginatum as an Early Symptom of Hereditary Angioedema: Case Report of 2 Newborns. Pediatrics 137:e20152411","DOI":"10.1542\/peds.2015-2411"},{"key":"5760_CR8","doi-asserted-by":"crossref","unstructured":"Magerl M, Doumoulakis G, Kalkounou I et\u00a0al. (2014) Characterization of prodromal symptoms in a\u00a0large population of patients with hereditary angio-oedema. Clin Exp Dermatol 39:298\u2013303","DOI":"10.1111\/ced.12285"},{"key":"5760_CR9","doi-asserted-by":"crossref","unstructured":"Camyar A, Bulut G, Ozisik M et\u00a0al. (2024) Genital Attacks in Hereditary Angioedema and Their Effects on Sexual Life. Medicina (Kaunas) 60","DOI":"10.3390\/medicina60111777"},{"key":"5760_CR10","doi-asserted-by":"crossref","unstructured":"Matheny MV, Craig T, Clark JY (2024) Edema of the Scrotum and Penile Shaft: An Uncommon Initial Presentation of Acquired Angioedema With Low C1-Inhibitor. Case Rep Urol 2024:9172329","DOI":"10.1155\/2024\/9172329"},{"key":"5760_CR11","doi-asserted-by":"crossref","unstructured":"Bocquet A, Bouillet L, Hardy G et\u00a0al. (2025) Management of hereditary angioedema with normal C1Inh: a\u00a0series of 163 French patients. Orphanet J Rare Dis 21:5","DOI":"10.1186\/s13023-025-04155-8"},{"key":"5760_CR12","doi-asserted-by":"crossref","unstructured":"Magerl M, Riedl MA, Arruda LK et\u00a0al. (2025) Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor. J\u00a0Allergy Clin Immunol Glob 4:100446","DOI":"10.1016\/j.jacig.2025.100446"},{"key":"5760_CR13","doi-asserted-by":"crossref","unstructured":"Bork K, Machnig T, Wulff K et\u00a0al. (2020) Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a\u00a0systematic review of qualitative evidence. Orphanet J Rare Dis 15:289","DOI":"10.1186\/s13023-020-01570-x"},{"key":"5760_CR14","doi-asserted-by":"crossref","unstructured":"Busse PJ, Christiansen SC (2020) Hereditary Angioedema. N Engl J Med 382:1136\u20131148","DOI":"10.1056\/NEJMra1808012"},{"key":"5760_CR15","doi-asserted-by":"crossref","unstructured":"Zuraw BL, Bork K, Bouillet L et\u00a0al. (2025) Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment. Clin Rev Allergy Immunol 68:24","DOI":"10.1007\/s12016-025-09027-4"},{"key":"5760_CR16","doi-asserted-by":"crossref","unstructured":"Bork K, Magerl M, Aygoren-Pursun E et\u00a0al. (2026) Algorithms in Allergy: Hereditary Angioedema. Allergy","DOI":"10.1111\/all.70241"},{"key":"5760_CR17","doi-asserted-by":"crossref","unstructured":"Zanichelli A, Azin GM, Wu MA et\u00a0al. (2017) Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency. J\u00a0Allergy Clin Immunol Pract 5:1307\u20131313","DOI":"10.1016\/j.jaip.2016.12.032"},{"key":"5760_CR18","doi-asserted-by":"crossref","unstructured":"Morsi H, Huissoon A, Grammatikos A et\u00a0al. (2025) A multi-centre UK-based survey on angioedema secondary to acquired C1 inhibitor deficiency. Clin Exp Immunol 219","DOI":"10.1093\/cei\/uxae121"},{"key":"5760_CR19","doi-asserted-by":"crossref","unstructured":"Trainotti S, Johnson F, Hahn J et\u00a0al. (2023) Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)-A Bicenter Retrospective Study on Diagnosis, Course, and Therapy. J\u00a0Allergy Clin Immunol Pract 11:3772\u20133779","DOI":"10.1016\/j.jaip.2023.09.003"},{"key":"5760_CR20","doi-asserted-by":"crossref","unstructured":"Castelli R, Zanichelli A, Cicardi M et\u00a0al. (2013) Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a\u00a0tight relationship. Crit Rev Oncol Hematol 87:323\u2013332","DOI":"10.1016\/j.critrevonc.2013.02.004"},{"key":"5760_CR21","doi-asserted-by":"crossref","unstructured":"Cicardi M, Zingale LC, Pappalardo E et\u00a0al. (2003) Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 82:274\u2013281","DOI":"10.1097\/01.md.0000085055.63483.09"},{"key":"5760_CR22","doi-asserted-by":"crossref","unstructured":"Wu MA, Castelli R (2016) The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. Clin Chem Lab Med 54:207\u2013214","DOI":"10.1515\/cclm-2015-0195"},{"key":"5760_CR23","doi-asserted-by":"crossref","unstructured":"Baeza ML, Gonzalez-Quevedo T, Caballero T et\u00a0al. (2021) Angioedema Due to Acquired Deficiency of C1-Inhibitor: a\u00a0Cohort Study in Spain and a\u00a0Comparison With Other series. J\u00a0Allergy Clin Immunol Pract","DOI":"10.1016\/j.jaip.2021.11.018"},{"key":"5760_CR24","doi-asserted-by":"crossref","unstructured":"Bork K, Staubach-Renz P, Hardt J (2019) Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate. Orphanet J Rare Dis 14:65","DOI":"10.1186\/s13023-019-1043-3"},{"key":"5760_CR25","doi-asserted-by":"crossref","unstructured":"Hahn J, Trainotti S, Hoffmann TK et\u00a0al. (2017) Drug-Induced Inhibition of Angiotensin Converting Enzyme and Dipeptidyl Peptidase 4\u00a0Results in Nearly Therapy Resistant Bradykinin Induced Angioedema: A\u00a0Case Report. Am J Case Rep 18:576\u2013579","DOI":"10.12659\/AJCR.901960"},{"key":"5760_CR26","doi-asserted-by":"crossref","unstructured":"Lochbaum R, Hoffmann TK, Greve J et\u00a0al. (2023) Concomitant medication in patients with bradykinin-mediated angioedema - there\u2019s more than ACE inhibitors. J\u00a0Dtsch Dermatol Ges 21:1283\u20131289","DOI":"10.1111\/ddg.15154"},{"key":"5760_CR27","doi-asserted-by":"crossref","unstructured":"Grumach AS, Riedl MA, Cheng L et\u00a0al. (2025) Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future. World Allergy Organ J 18:101060","DOI":"10.1016\/j.waojou.2025.101060"},{"key":"5760_CR28","doi-asserted-by":"crossref","unstructured":"Aulenbacher F, Gutsche A, Farkas H et\u00a0al. (2025) Classification of angioedema types using decision tree modeling. Front Immunol 16:1697143","DOI":"10.3389\/fimmu.2025.1697143"},{"key":"5760_CR29","unstructured":"Zuberbier T, Abdul Hameed Ansari Z, Abdul Latiff AH et\u00a0al. (2026) The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. Allergy"},{"key":"5760_CR30","doi-asserted-by":"crossref","unstructured":"Cicardi M, Zanichelli A (2010) Acquired angioedema. Allergy Asthma Clin Immunol 6:14","DOI":"10.1186\/1710-1492-6-14"},{"key":"5760_CR31","doi-asserted-by":"crossref","unstructured":"Wilkerson RG, Winters ME (2023) Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema. Immunol Allergy Clin North Am 43:513\u2013532","DOI":"10.1016\/j.iac.2022.10.013"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05760-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-026-05760-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05760-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:04:35Z","timestamp":1788451475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-026-05760-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5760"],"URL":"https:\/\/doi.org\/10.1007\/s00105-026-05760-9","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"28 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.\u00a0Trainotti und U.\u00a0Lippert geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}